$Biogen (BIIB.US)$ The drugmaker's stock rose in premarket t...
$Biogen(BIIB.US$ The drugmaker's stock rose in premarket trading after Needham initiated coverage of the stock with a buy rating, saying in a note to clients on Wednesday that the company's controversial Alzheimer's drug Aduhelm will be a big seller for the company long term.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Qianmeng : we need to know dark side of human. Many national insurance or medical system prefer elders dying early for cutting cost, and they did that on covid. Nursing homes have same trend on elders whose cost is paid by government in a discounted rate. If people have huge life insurance, their child would consider more conservative treatment to get money earlier. There are just so many negative voice talking![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
on purpose as they care cost more. Elders would eventually realize. I’ll hold anyway, will load more if drops more. Major treat is LLY and SAVA’s trial. just place bet.